Post-injury treatment with 7,8dihydroxyflavone, a TrkB receptor agonist, protects against experimental traumatic brain injury via PI3K/Akt signaling

Wu CH, Hung TH, Chen CC, Ke CH, Lee CY, Wang PY, Chen SF. Post-injury treatment with 7,8dihydroxyflavone, a TrkB receptor agonist, protects against experimental traumatic brain injury via PI3K/Akt signaling. PLoS One 9(11):e113397, 2014.

Year:

2014

Tissue Type:

Cell Type:

Organ Type:

System Type:

12 min read

Absract

Click to Read the full publication

Get In Touch

At Flexcell® International Corporation, we understand that our commitment to the highest quality products and customer service are core to our business. Reach out to us today to see how we can apply those principals to your business.